Docetaxel/anthracycline combinations for breast cancer treatment - Wikidata - wikimedia - TriplyDB

Docetaxel/anthracycline combinations for breast cancer treatment

Docetaxel/anthracycline combinations for breast cancer treatment

http://www.wikidata.org/entity/Q28288899

about

Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance ASDCD: antifungal synergistic drug combination database Progress and problems in the application of focused ultrasound for blood-brain barrier disruption.Homoharringtonine induces apoptosis and inhibits STAT3 via IL-6/JAK1/STAT3 signal pathway in Gefitinib-resistant lung cancer cells.Tualang honey promotes apoptotic cell death induced by tamoxifen in breast cancer cell lines.Pegylated liposomal doxorubicin and gemcitabine in the front-line treatment of recurrent/metastatic breast cancer: a multicentre phase II study.CE-LIF method for the separation of anthracyclines: application to protein binding analysis in plasma using ultrafiltration.High-throughput screen identifies disulfiram as a potential therapeutic for triple-negative breast cancer cells: interaction with IQ motif-containing factors Combined Treatment with Stattic and Docetaxel Alters the Bax/Bcl-2 Gene Expression Ratio in Human Prostate Cancer Cells High-throughput pharmacogenetics identifies SLCO1A2 polymorphisms as candidates to elucidate the risk of febrile neutropenia in the breast cancer RAPP-01 trial.Neoadjuvant chemotherapy regimens in treatment of breast cancer: a systematic review and network meta-analysis protocol.

P2860

Q28269714-9046D983-8CD3-4121-9CD6-B3AF6E13820B Q28539135-851BFDD8-E527-4220-BAEB-8DD5F7AEF09B Q30487878-B9246E35-EEE8-476F-9A40-547AF0F83A7D Q35844693-7BDB1D90-8F25-4EBF-889D-0B5ED0EF5F81 Q36651226-E3251DC4-4757-49DB-A268-15B676CC1B77 Q36740641-DFE15DA4-AEF8-4DEF-B4DE-231E7F40A619 Q36846351-8FAA4672-179F-4D60-8F53-F06D73114023 Q37420053-BC8C467C-388F-4DF1-BED5-07E5272CAE8C Q38723854-7279D77A-C9B8-40AC-87D2-49C23ED932C5 Q41441391-A08F8966-F86B-48FB-B770-69D70D29EF55 Q55466335-F3A4883D-0AAA-43E2-A151-08FEC1BCD31E

P2860

Docetaxel/anthracycline combinations for breast cancer treatment

http://www.wikidata.org/entity/Q28288899

description

2007 nî lūn-bûn

@nan

2007 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի մարտին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Docetaxel/anthracycline combinations for breast cancer treatment

@ast

Docetaxel/anthracycline combinations for breast cancer treatment

@en

Docetaxel/anthracycline combinations for breast cancer treatment

@nl

type

label

Docetaxel/anthracycline combinations for breast cancer treatment

@ast

Docetaxel/anthracycline combinations for breast cancer treatment

@en

Docetaxel/anthracycline combinations for breast cancer treatment

@nl

prefLabel

Docetaxel/anthracycline combinations for breast cancer treatment

@ast

Docetaxel/anthracycline combinations for breast cancer treatment

@en

Docetaxel/anthracycline combinations for breast cancer treatment

@nl

P1433

Q28288899-2D2E7A74-CBD7-4375-B51E-420D51FD9CC2

P1476

Q28288899-0ADEF53F-2475-423C-A30B-89EDF83966F6

P2860

Q28288899-02DDD0A0-7C90-4C12-BC07-68124EDFA03B

Q28288899-169C3D6A-1820-4006-936F-34954956E5C6

Q28288899-2BDB0852-52EF-434A-AC46-FDFA1314952A

Q28288899-2F2A444D-8301-4136-91CF-F122DF80BFB9

Q28288899-3233625B-2355-444E-A569-879216479827

Q28288899-33AA597C-5919-4323-AE95-DCA3DEE13A44

Q28288899-447B5C17-CF7A-4A6C-A259-3A535CD4B47E

Q28288899-57FA08E9-9A1E-4820-95CB-0068344F6CDB

Q28288899-5AFBE515-7BC7-421D-B831-AFE2EA96DE76

Q28288899-61802601-0461-44A8-BCE3-CD49867B1F55

P304

Q28288899-B10F3B4C-FF17-4063-B291-02C6E0192572

P31

Q28288899-2A50A13F-9CFE-40D1-90E0-777683666A9C

P356

Q28288899-D3876E95-B65B-47AA-AF58-69CAB0EB10CF

P407

Q28288899-6A32B217-0EDA-4F2B-8ADB-65545A85E7E7

P433

Q28288899-98FCB76A-A58A-49F7-8566-3867307CB889

P478

Q28288899-DB41915F-E265-4E12-A2FB-CD154D6D80FD

P50

Q28288899-AC59B04A-8F0E-4333-AFD4-BB9E93D012E4

P577

Q28288899-FF656E39-320A-4D75-AA5F-BE6E2C36B365

P698

Q28288899-37FF3F15-4911-4DFF-B87D-7834BA7C2185

P356

14656566.8.4.485

P1433

Expert Opinion on Pharmacotherapy

P1476

Docetaxel/anthracycline combinations for breast cancer treatment

@en

P2860

Phase II to III study comparing doxorubicin and docetaxel with fluorouracil, doxorubicin, and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: results of a Dutch Community Setting Trial for the Clinical Trial Gr

Phase I, dose-finding study of capecitabine in combination with docetaxel and epirubicin as first-line chemotherapy for advanced breast cancer.

Docetaxel: an update of its use in advanced breast cancer.

The taxoids. Comparative clinical pharmacology and therapeutic potential.

Doxorubicin with cyclophosphamide followed by docetaxel every 21 days compared with doxorubicin and docetaxel every 14 days as preoperative treatment in operable breast cancer: the GEPARDUO study of the German Breast Group.

Multicenter randomized trial comparing sequential with concomitant administration of doxorubicin and docetaxel as first-line treatment of metastatic breast cancer: a Spanish Breast Cancer Research Group (GEICAM-9903) phase III study.

Combination of docetaxel, epirubicin and vinorelbine administered every 2 weeks as first-line therapy in patients with metastatic breast cancer: a dose-finding study.

Phase II trial combining docetaxel and doxorubicin as neoadjuvant chemotherapy in patients with operable breast cancer.

Gemcitabine, epirubicin and docetaxel as primary systemic therapy in patients with early breast cancer: results of a multicentre phase I/II study.

Phase I and pharmacokinetic study of docetaxel in combination with epirubicin and cyclophosphamide in advanced cancer: dose escalation possible with granulocyte colony-stimulating factor, but not with prophylactic antibiotics.

P304

485-95

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.8.4.485

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Gunter von Minckwitz

P577

2007-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17309343

http://www.w3.org/2001/XMLSchema#string